Andrew Galler
Stock Analyst at Morgan Stanley
(0.58)
# 4,081
Out of 5,182 analysts
30
Total ratings
33.33%
Success rate
-15.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrew Galler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMCR Immunocore Holdings | Maintains: Equal-Weight | $34 → $36 | $28.79 | +25.04% | 14 | Nov 10, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Equal-Weight | $14 → $15 | $14.49 | +3.52% | 5 | Nov 9, 2023 | |
| SLN Silence Therapeutics | Initiates: Equal-Weight | $18 | $7.70 | +133.77% | 1 | Dec 9, 2022 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Equal-Weight | $41 → $37 | $70.13 | -47.24% | 2 | Nov 29, 2022 | |
| IONS Ionis Pharmaceuticals | Maintains: Overweight | $57 → $56 | $71.78 | -21.98% | 2 | Nov 10, 2022 | |
| VIR Vir Biotechnology | Maintains: Underweight | $15 → $18 | $10.28 | +75.10% | 2 | Nov 4, 2022 | |
| PTCT PTC Therapeutics | Initiates: Equal-Weight | $54 | $70.26 | -23.14% | 1 | Sep 9, 2022 | |
| HALO Halozyme Therapeutics | Initiates: Overweight | $50 | $63.86 | -21.70% | 1 | Sep 9, 2022 | |
| ADCT ADC Therapeutics | Initiates: Outperform | $44 | $3.77 | +1,067.11% | 1 | Nov 9, 2021 | |
| MRNA Moderna | Initiates: Outperform | $304 | $47.14 | +544.89% | 1 | Nov 9, 2021 |
Immunocore Holdings
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $34 → $36
Current: $28.79
Upside: +25.04%
Amicus Therapeutics
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $14.49
Upside: +3.52%
Silence Therapeutics
Dec 9, 2022
Initiates: Equal-Weight
Price Target: $18
Current: $7.70
Upside: +133.77%
Arrowhead Pharmaceuticals
Nov 29, 2022
Maintains: Equal-Weight
Price Target: $41 → $37
Current: $70.13
Upside: -47.24%
Ionis Pharmaceuticals
Nov 10, 2022
Maintains: Overweight
Price Target: $57 → $56
Current: $71.78
Upside: -21.98%
Vir Biotechnology
Nov 4, 2022
Maintains: Underweight
Price Target: $15 → $18
Current: $10.28
Upside: +75.10%
PTC Therapeutics
Sep 9, 2022
Initiates: Equal-Weight
Price Target: $54
Current: $70.26
Upside: -23.14%
Halozyme Therapeutics
Sep 9, 2022
Initiates: Overweight
Price Target: $50
Current: $63.86
Upside: -21.70%
ADC Therapeutics
Nov 9, 2021
Initiates: Outperform
Price Target: $44
Current: $3.77
Upside: +1,067.11%
Moderna
Nov 9, 2021
Initiates: Outperform
Price Target: $304
Current: $47.14
Upside: +544.89%